Staging of acute pancreatitis. Is it important? (Q33724442)

28 July 2017

1 reference

title

Staging of acute pancreatitis. Is it important? (English)

1 reference

28 July 2017

McKay CJ

1

1 reference

28 July 2017

Imrie CW

series ordinal

2

1 reference

28 July 2017

publication date

1 August 1999

1 reference

Surgical Clinics of North America

28 July 2017

published in

1 reference

28 July 2017

volume

79

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

733-743

1 reference

Acute pancreatitis: value of CT in establishing prognosis

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992.

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

Prediction of severity in acute pancreatitis: prospective comparison of three prognostic indices

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

Clinical usefulness of polymorphonuclear elastase in predicting the severity of acute pancreatitis: results of a multicentre study

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

Evaluation of the clinical usefulness of APACHE II and SAPS systems in the initial prognostic classification of acute pancreatitis: a multicenter study

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins C-reactive protein, alpha 1-antitrypsin, and protease inhibitor alpha 2-macroglobulin

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

Trypsinogen activation peptides (TAP) concentrations in the peritoneal fluid of patients with acute pancreatitis and their relation to the presence of histologically confirmed pancreatic necrosis

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

Early localization of necrosis by contrast-enhanced computed tomography can predict outcome in severe acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

APACHE II: a severity of disease classification system

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

APACHE-II score for assessment and monitoring of acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis.

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

Rapid-bolus contrast-enhanced dynamic computed tomography in acute pancreatitis: A prospective study

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

Prospective placebo-controlled randomized trial of lexipafant in predicted severe acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

A compaative study of methods for the prediction of severity of attacks of acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

Magnetic resonance imaging in detecting acute oedematous and haemorrhagic pancreatitis: an experimental study in pigs

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

The Timing of Biliary Surgery in Acute Pancreatitis

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

PMN-Elastase in Comparison with CRP, Antiproteases, and LDH as Indicators of Necrosis in Human Acute Pancreatitis

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

Inflammatory response in the early prediction of severity in human acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems

1 reference

https://api.crossref.org/works/10.1016/S0039-6109(05)70039-6

7 January 2021

10.1016/S0039-6109(05)70039-6

Identifiers

DOI

1 reference

28 July 2017

1 reference